[1] CHUA M L,WEE J T,HUI E P,et al.Nasopharyngealcarcinoma[J].Lancet,2016,387(10022):1012-1024.
[2] CHEN W Q,ZHENG R S,ZHANG S W,et al.Report of cancerincidence and mortality in China,2012[J].China Cancer,2016,25(1):1-8.
[3] CAO S M,YANG Q,GUO L,et al.Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma:A phase Ⅲ multicentre randomised controlled trial[J].Eur J Cancer,2017,75:14-23.
[4] LI W F,CHEN L,SUN Y,et al.Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma[J].Chin J Cancer,2016,35(1):94.
[5] YANG L,HONG S,WANG Y,et al.Development and External Validation of Nomograms for Predicting Survival in Nasopharyngeal Carcinoma Patients after Definitive Radiotherapy[J].Sci Rep,2015,5:15638.
[6] ZHANG M X,LI J,SHEN G P,et al.Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy:A 10-year experience with a large cohort and long follow-up[J].Eur J Cancer,2015,51:2587-2595.
[7] YAN D F,ZHANG W B,KE S B,et al.The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma[J].BMC Cancer,2017,17(1):678.
[8] 刘念龙,张兰芳,何侠,等.磁共振弥散加权成像在鼻咽癌颅底放疗疗效评价中的应用[J].现代医学,2014,41(11):821-824.
[9] 孙涛,韩善清,汪家旺.PET/CT成像原理、优势及临床应用[J].中国医学物理学杂志,2010,21(1):1581-1587.
[10] LEE S J,KAY C S,KIM Y S,et al.Prognostic value of nodal SUVmax of 18F-FDG PET/CT in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy[J].Radiat Oncol J,2017,35(4):306-316.
[11] 孟庆乐,杨瑞,曹艳,等.SPECT/CT融合显像在99Tcm-MIBI甲状腺亲肿瘤显像中的应用[J].中国医疗设备,2014,29(2):121-125.
[12] 贾莉,邹天宁,夏正武,等.99mTc-MIBI乳腺显像评价乳腺癌新辅助化疗效果的临床价值[J].现代医学,2014,42(1):4-8.
[13] DU C,YING H,ZHOU J,et al.Prediction of the response to docetaxel-based chemotherapy for locoregionally advanced nasopharyngeal carcinoma:the role of double-phase (99m)Tc-MIBI SPECT/CT[J].Med Oncol,2014,31(2):833.
[14] SILOV G,TAŞDEMIR A,OZDAL A,et al.Radionuclide imaging for breast cancer diagnosis and management:is technetium-99m tetrofosmin uptake related to the grade of malignancy?[J]. Hell J Nucl Med,2014,17(2):87-89.
[15] ARBAB A S,KOIZUNI K,TOYAMAK A,et al.Technetium-99m-tetrofosmin,technetium-99m-MIBI and thallium-201 uptake in rat myocardial cell[J].J Nucl Med,1998,36:226-271.
[16] RODRIGUES M,CHEHNE F,KALINOWSKA W,et al.Uptake of 99mTc-MIBI and 99mTc-tetrofosmin into malignant versus nonmalignant breast cell lines[J].J Nucl Med,2000,41(9):1495-1499.
[17] KAO C H,HSIEH J F,TSAI S C,et al.Paclitaxel-based chemotherapy for non-small cell lung cancer:predicting the response with 99mTc-tetrofosmin chest imaging[J].J Nucl Med,2001,42(1):17-20. |